PE Ratio: 45.42

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/E ratio high or low?

The P/E ratio of 45.42 is 31% above its 5-year average of 34.59, near the low end of its 5-year range (18.75–147.90).

As of 2026-10-06T13:30:36.086Z. 42.65% below its 12-month average of 79.20.

PE Ratio (45.42) = Close Price ($37.13) / Diluted TTM EPS ($0.82)

ASTH PE Ratio Metrics

P/E vs. its own history

At 45.4, P/E is above its 5-year median — higher than 76% of readings in its 5-year history.

P/E Comparison

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PE Ratio FAQ

What is the P/E ratio for Astrana Health, Inc. (ASTH)?

The P/E ratio for ASTH stock is 45.42.

Is Astrana Health, Inc.'s P/E ratio high or low?

The P/E ratio of 45.42 is 31% above its 5-year average of 34.59, near the low end of its 5-year range (18.75–147.90).

What is the TTM average P/E ratio for Astrana Health, Inc. (ASTH)?

The TTM average P/E ratio for ASTH stock is 79.20.

What is the 3Y average P/E ratio for Astrana Health, Inc. (ASTH)?

The 3Y average P/E ratio for ASTH stock is 41.60.

What is the 5Y average P/E ratio for Astrana Health, Inc. (ASTH)?

The 5Y average P/E ratio for ASTH stock is 34.59.

Showing the most recent 260 of 1,131 data points. The chart above shows the full history.

Related Metrics